Wilson disease
Conditions
Interventions
Nanooptics. Intervention:liver biopsy,one or two times at the routine biopsy for diagnostic purpose (in such case, residual specimens will be used as observational study). However,if WD scoring system
s clear understanding and positive agreement with informed consent about the needs of biopsy and enrolment in this study.
Sponsors
Fujita Health University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Wilson disease (& suspected cases) by liver tests and copper metabolic tests
Exclusion criteria
Exclusion criteria: no
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Copper content and distribution in livers of Wilson disease | — |
Secondary
| Measure | Time frame |
|---|---|
| Copper content and distribution in livers of non-Wilson disease (WD suspected cases). | — |
Countries
Japan,Asia(except Japan)
Contacts
Public ContactAkihiro Matsuura
Fujita Health University Research Integrity Office, Quantum Beam Diagnostics
Outcome results
None listed